Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Descemet membrane endothelial keratoplasty and refractive surgery

Tong, C. Mayaa,b; Baydoun, Lamisa,c; Melles, Gerrit R.J.a,c

Current Opinion in Ophthalmology: July 2017 - Volume 28 - Issue 4 - p 316–325
doi: 10.1097/ICU.0000000000000380
REFRACTIVE SURGERY: Edited by Jimmy K. Lee
Buy
Editor's Choice

Purpose of review Descemet membrane endothelial keratoplasty (DMEK) has become a first-line treatment in corneal endothelial diseases because of its exceptional clinical outcomes and low complication rates. Because of its improved refractive predictability, DMEK is now also considered for managing cases with endothelial decompensation following previous refractive procedures, or in combination with those. This article reviews the clinical outcomes in these cases and discusses the possibility of refractive interventions following DMEK.

Recent findings DMEK has been successfully performed in eyes after laser in-situ keratomileusis, eyes after anterior chamber intraocular lens (IOL) implantation and aphakic eyes. Often, DMEK is combined with cataract surgery (triple-DMEK). Initial reports on reducing the refractive cylinder by toric IOL implantation are available. Although there are some reports on phacoemulsification and IOL implantation after phakic DMEK, reports on laser refractive procedures following DMEK are lacking.

Summary In contrast to earlier keratoplasty techniques, DMEK induces on average only mild refractive shifts owing to the ‘natural’ restoration of the cornea. As such, DMEK may be ideal in managing corneal decompensation in refractive patients. However, further studies are required to assess the safety and efficacy of DMEK after refractive treatment and of refractive procedures following DMEK.

aNetherlands Institute for Innovative Ocular Surgery, Rotterdam, The Netherlands

bUniversity of Alberta, Edmonton, Alberta, Canada

cMelles Cornea Clinic Rotterdam, Rotterdam, The Netherlands

Correspondence to Gerrit R.J. Melles, MD, PhD, Netherlands Institute for Innovative Ocular Surgery, Laan op Zuid 88, 3071AA Rotterdam, The Netherlands. Tel: +31 10 297 4444; fax: +31 10 297 4440; e-mail: research@niios.com

Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.